Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Biocept Inc    BIOC

BIOCEPT INC (BIOC)
Mes dernières consult.
Most popular
  Report  
Delayed Quote. Delayed  - 07/20 10:00:00 pm
6.22 USD   -4.01%
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/16/2018 07/17/2018 07/18/2018 07/19/2018 07/20/2018 Date
6.99(c) 6.24(c) 6.3(c) 6.48(c) 6.22(c) Last
1 175 845 427 926 506 730 844 555 234 562 Volume
-2.78% -10.73% +0.96% +2.86% -4.01% Change
More quotes
Financials (USD)
Sales 2018 4,16 M
EBIT 2018 -23,6 M
Net income 2018 -23,6 M
Debt 2018 -
Yield 2018 -
Sales 2019 4,99 M
EBIT 2019 -22,3 M
Net income 2019 -22,3 M
Debt 2019 -
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
Capi. / Sales2018 106x
Capi. / Sales2019 88,5x
Capitalization 442 M
More Financials
Company
Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells.It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests... 
More about the company
Latest news on BIOCEPT INC
07/20BIOCEPT : Enters into Agreement with Alliance Global FZ to Market and Distribute..
AQ
More news
Sector news : Diagnostic & Testing Substances
07/18Smiths Group medical unit hurt by EU medical devices regulation
RE
07/17BAXTER INTERNATIONAL : Releases FDA Warning Letter for 2017 Inspection in India
DJ
07/11Brazil prosecutors allege jailed GE executive helped company partake in medic..
RE
07/11MEDTRONIC : Gets FDA Approval for Less-Invasive Heart Pump Implant Procedure
DJ
07/09BECTON DICKINSON AND : Completes Acquisition of TVA Medical
DJ
More sector news : Diagnostic & Testing Substances
Latest Tweets
07/21Simpler, one-dose treatment to prevent malaria relapse OK'd $BIOC #BIOC #Heal.. 
07/20Trump nominates 4 career diplomats to highest-rank (Career Ambassador) in For..
18
07/19Biocept Reminds Investors of Today's Deadline to be a Shareholder of Record  
07/18Biocept $BIOC Sees Strong Trading Volume  
07/1621 Stocks Moving In Monday's Pre-Market Session
2
More tweets
Qtime:68
News from SeekingAlpha
07/17Midday Gainers / Losers (07/17/2018) 
07/16PREMARKET LOSERS AS OF 9 : 05 am (07/16/2018) 
07/13Midday Gainers / Losers (07/13/2018) 
07/13HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am (7/13/2018) 
07/13PREMARKET GAINERS AS OF 9 : 05 am (07/13/2018) 
Chart BIOCEPT INC
Duration : Period :
Biocept Inc Technical Analysis Chart | BIOC | US09072V4023 | 4-Traders
Technical analysis trends BIOCEPT INC
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Average target price 19,5 $
Spread / Average Target 214%
EPS Revisions
Managers
NameTitle
Michael W. Nall President, Chief Executive Officer & Director
David F. Hale Non-Executive Chairman
Timothy C. Kennedy CFO, Senior VP-Operations & Secretary
Lyle J. Arnold Chief Scientific Officer & SVP-Research
Veena M. Singh Senior Vice President & Senior Medical Director
Sector and Competitors
1st jan.Capitalization (M$)
BIOCEPT INC-70.12%442
BIOMÉRIEUX-1.59%10 222
DIASORIN SPA30.74%6 343
AUTOBIO DIAGNOSTICS CO LTD48.42%4 948
MACCURA BIOTECHNOLOGY CO LTD--.--%2 194
SIEGFRIED HOLDING AG31.17%1 810